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Hopelessness, determined as a 
system of negative expectancies 
concerning oneself and one’s fu-
ture, has been shown to be a pre-
dictor of cardiovascular morbidity 
and mortality, independently of 
depression. This study indicates 
that hopelessness is also associ-
ated with metabolic syndrome. 
Additionally, physical activity is 
inversely associated with feelings 
of hopelessness. Regular physical 
activity may protect one from an 
emergence of hopelessness, and 
thus enhance subjective well-be-
ing and an optimistic perspective 
in life.   
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ABSTRACT:  
 
The prevalence of metabolic syndrome is rapidly growing worldwide, increasing the risk for diabetes and 
cardiovascular disease. Hopelessness, determined as a system of negative expectancies concerning oneself 
and one’s future, has shown to be a predictor of cardiovascular morbidity and mortality, independently of 
depression. Psychosocial factors have also been associated with features of metabolic syndrome. However, 
the direction of this association, possible mediating factors and the extent of psychosocial factors related 
with metabolic syndrome itself are not known.  
The purpose of this study was to provide new information about the aetiology of metabolic syndrome 
and depressive symptoms, to disentangle the relationships among them and to clarify possible mediating 
factors, such as physical activity and low-grade inflammation, underlying the associations. To better target 
high-risk groups for treatment and prevention of metabolic syndrome, depressive symptoms and their con-
sequences, such knowledge is necessary.   
The Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) is a population-based cohort study with a 
representative sample of 2682 middle-aged male participants. The data on the features and components of 
metabolic syndrome were collected on clinical examinations. Physical activity, feelings of hopelessness and 
depressive symptoms were estimated by detailed questionnaires. Follow-up data were collected 4 and 11 
years after the baseline. 
This study showed that non-diabetic men with high levels of hopelessness were twice more likely to have 
metabolic syndrome than men who were less hopeless, independently of traditional risk factors, body mass 
index and other depressive symptoms. In addition, non-diabetic men with both low-grade inflammation and 
depressive symptoms were more likely to develop abdominal obesity (waist girth at least 102 cm) and meta-
bolic syndrome than men with neither of these risk markers even after adjusting for traditional risk factors.   
The study also showed that those men exercising for at least 2.5 h per week moderate-to-vigorous leisure-
time physical activity (LTPA) were 28% less likely to express feelings of hopelessness than physically inac-
tive men even after adjustment for traditional risk factors and depressive symptoms. Men engaging in mod-
erate-to-vigorous LTPA at least 2.5 hours per week had 35% lower risk to feel hopeless about their future 
and reaching goals 4 years later than inactive men at baseline. After 11 years the trend was still similar, indi-
cating protective effect of LTPA.  
This study indicates that that in addition to focusing on the traditional risk factors of cardiovascular dis-
ease, the emotional state and expectations of individuals should be taken into account in the prevention and 
treatment of metabolic syndrome and its consequences. This study also agrees with growing evidence that 
regular LTPA contributes to mental health. A physically active lifestyle may help one to maintain or gain 
more optimistic perspective on the future and oneself. 
 
National Library of Medical Classification: WA 306, WG 120, WK 820, WM 171.5 
Medical Subject Headings: Metabolic syndrome X; Cardiovascular Diseases; Depression; Men's Health; Life 
Style; Psychophysiologic Disorders; Risk Factors; Middle Aged; Cohort studies; Follow-Up Studies; Finland 
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TIIVISTELMÄ: 
 
Metabolinen oireyhtymä tarkoittaa tilaa, jossa esiintyy samanaikaisesti poikkeavuuksia sokeri-, insuliini- ja 
rasva-aineenvaihdunnassa, kohonnutta verenpainetta sekä keskivartaloon painottuvaa ylipainoa. Nämä 
altistavat oireyhtymän keskeisille komplikaatioille eli tyypin 2 diabeteksen kehittymiselle sekä sydän- ja 
verisuonisairauksille. Fyysisesti passiivinen elämäntapa ja epäterveelliset ruokatottumukset ovat keskeisiä 
tekijöitä metabolisen oireyhtymän kehittymisessä. Lisäksi psykososiaalisilla tekijöillä, kuten masennuksella, 
tiedetään olevan yhteys metaboliseen oireyhtymään, mutta yhteyden syy-seuraussuhde sekä välittävät me-
kanismit tunnetaan huonosti. Aiemmissa tutkimuksissa myös toivottomuudella eli kielteisillä odotuksilla 
itseään ja tulevaisuuttaan kohtaan, on todettu olevan itsenäinen, masennusoireista riippumaton yhteys sy-
dän- ja verisuonitauteihin. Elimistön kudostulehduksen tiedetään liittyvän sekä masennuksen että sydän- ja 
verisuonitautien syntyyn ja etenemiseen. 
Tämän tutkimuksen tarkoituksena oli lisätä tietoa metabolisen oireyhtymän ja psyykkisten oireiden etio-
logiasta ja näiden välisistä yhteyksistä. Lisäksi tavoitteena oli selventää mahdollisten välittävien mekanismi-
en, kuten liikunta-aktiivisuuden ja tulehdustekijöiden roolia psyykkisten tekijöiden ja metabolisen terveyden 
välillä. Tätä ymmärrystä tarvitaan metabolisen oireyhtymän ja mielenterveysongelmien ehkäisyssä ja hoi-
dossa. 
Tämä tutkimus oli osa Itä-Suomen Yliopiston laajaa väestöpohjaista Sepelvaltimotaudin Vaaratekijätut-
kimusta. Tutkimuksessa kartoitettiin 2682 keski-ikäisen miehen masennusoireita kattavilla kyselylomakkeil-
la, määritettiin sydän- ja verisuonitauteihin liittyvät riskitekijät, arvioitiin liikunta-aktiivisuus sekä mitattiin 
kestävyyskunto. Seurantatutkimukset suoritettiin 4 ja 11 vuoden kuluttua. 
Tutkimus osoitti, että miehillä, joilla oli toivottomuuden tunteita itseään ja tulevaisuuttaan kohtaan, me-
tabolinen oireyhtymä oli yleisempää kuin miehillä, joilla toivottomuuden tunteita ei ollut, riippumatta muis-
ta masennusoireista. Tutkimus osoitti myös, että masennusoireiden esiintyminen yhdessä kohonneiden ve-
ren tulehdusarvojen kanssa lisäsi huomattavasti riskiä vyötärölihavuuden kehittymiseen 11 vuoden seuran-
nassa. Toisaalta tutkimuksen keskeisenä löydöksenä oli vähäisen liikunta-aktiivisuuden ja toivottomuuden 
välinen selkeä yhteys muista masennusoireista riippumatta. Säännöllinen kohtuullisesti kuormittava liikun-
ta suojasi toivottomuuden tunteilta seurantatutkimuksen aikana. 
Tutkimustulosten mukaan kansanterveyden edistämistyössä tulisi ottaa huomioon perinteisten riskiteki-
jöiden lisäksi yksilön henkiset voimavarat ja elämänasenne. Tutkimus vahvistaa aiempaa näyttöä liikunnan 
myönteistä vaikutuksista psyykkiseen terveyteen. Säännöllinen liikunta voi ehkäistä toivottomuuden tuntei-
ta ja näin edistää optimistista elämänasennetta ja mielenterveyttä.  
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The prevalence of metabolic syndrome is rapidly growing worldwide (Zimmet et al. 2005), 
but the role of psychosocial issues in its development is poorly understood. Central obesi-
ty and associated insulin resistance are crucial factors in the pathogenesis of metabolic 
syndrome (Laaksonen et al. 2002a, 2004a). Suggestions that behavioral and psychosocial 
factors are associated with features of metabolic syndrome (Laaksonen et al. 2004a; Vii-
namäki et al. 2009) have been made. However, the time order of the associations, mediat-
ing factors underlying the associations and the role of psychosocial factors in the associa-
tions itself are not known. 
Hope is an important determinant of subjective well-being (Scheier and Carver 1985). 
Hopelessness, a major symptom of depression, is defined as a cluster of negative expec-
tancies concerning a person and his or her future (Stotland 1969). Lack of hope is asso-
ciated with various manifestations of psychological morbidity (Haatainen et al. 2004). 
Hopelessness, independently of depression, is also associated with increased incidence of 
hypertension and myocardial infarction, accelerated progression of carotid atherosclerosis, 
as well as cardiovascular and overall mortality (Anda et al. 1997; Everson et al. 1996, 1997, 
2000; Stern et al. 2001; Whipple et al. 2009; Do et al. 2010).  
Higher levels of leisure-time physical activity (LTPA) and cardiorespiratory fitness pro-
tect against chronic diseases, such as metabolic syndrome (Laaksonen et al. 2002b; Lakka 
et al. 2003), type 2 diabetes (Laaksonen et al. 2005a), and cardiovascular disease (CVD) 
(Lakka et al. 1994; Lakka et al. 2002). Moreover, a physically active lifestyle may improve 
mental health (Mead et al. 2009). Experimental studies have shown that physical exercise 
seems to decrease symptoms of depression (Lawlor and Hopker 2001; Dunn et al. 2005; 
Dunn 2009). This evidence, however, comes mainly from cross-sectional studies on physi-
cal activity and depression. Prospective studies on physical activity and depression are 
scarce. In previous studies, psychological outcome has ranged from clinical depression to 
depressive symptoms and mood. The relationship between physical activity, cardiorespi-
ratory fitness and feelings of hopelessness has not been previously studied. It is plausible 
that physical exercise has a stronger impact on certain depressive symptoms than on other 
mental symptoms. The purpose of the thesis is to provide new information about the aeti-
ology of metabolic syndrome and depressive symptoms, especially hopelessness, to disen-
tangle the relationships among them and to clarify possible mediating factors underlying 
the associations. The focus of the thesis was on middle-aged men and their physical activi-
ty and their mental and physical health. Although the health of Finnish men has improved 
during the past decades, we are not approaching an ideal state. The prevalence of obesity 
and associated type 2 diabetes continues to escalate. Psychiatric diseases are the leading 
cause of disability. Physical inactivity is the most common modifiable risk of public health, 
and most life-style interventions do not reach people who critically need them. Mental 
disorders often hamper the implementation of the healthier life-style. Health-care profes-
sionals need tools to identify high-risk individuals and to refer them to life-style interven-
tions. 
1 Introduction 
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2.1 METABOLIC SYNDROME 
2.1.1 Pathogenesis of metabolic syndrome 
Metabolic syndrome is a cluster of different risk factors for diabetes and CVD. These risk 
factors, including dysglycemia, hypertension, dyslipidemia and abdominal obesity, share 
common pathogenetic processes. The underlying mechanisms of metabolic syndrome still 
remain unclear, but central obesity and associated insulin resistance nonetheless play an 
important role. It is not known whether visceral fat causes insulin resistance or is just as-
sociated with insulin resistance (Kirk and Klein 2009). According to one hypothesis, the 
release of fatty acids from visceral adipose tissue causes insulin resistance, because these 
fatty acids are delivered directly to the liver through portal vein (Nielsen et al. 2003).  Free 
fatty acids decrease the ability of insulin to suppress hepatic glucose production resulting 
in inappropriate fasting and postprandial gluconeogenesis. In addition, an increase in the 
flux of non-esterified fatty acids enhances the production of very-low-density lipoprotein, 
causing higher triglyceride and lower high-density lipoprotein (HDL) concentrations in 
plasma. Ectopic accumulation of fat in skeletal muscle and liver is also associated with in-
sulin resistance in these tissues (Krssak 1999; Seppälä-Lindroos et al. 2002). Free fatty acids 
themselves may also cause vasoconstriction (Tripathy et al. 2003) and increase sodium 
reabsorption (DeFonzo et al. 1975), leading to hypertension. 
Furthermore, adipose tissue produces inflammatory cytokines, such as tumour necrosis 
factor-alpha (TNF-α), interleukin-6 (IL-6) and IL-8, which can induce insulin resistance 
(Perseghin et al. 2003) and may play a critical role in the pathogenesis of metabolic syn-
drome. There are also many other factors that are associated with insulin resistance, such 
as increased serum concentrations of prothrombotic factors and uric acid, microalbuminu-
ria, reduced low-density lipoprotein (LDL) particle size, increased serum concentrations of 
adiponectin, abnormal sex hormone metabolism, and disturbed cortisol metabolism, that 
are not included in the diagnostic criteria for metabolic syndrome (Laaksonen et al. 2004a, 
2004b, 2004c; Eckel et al. 2005). Also considered is the role of prenatal and early-life influ-
ences as well as genetic factors in the development of metabolic syndrome (Alberti et al. 
2009). 
Behavioral and psychosocial factors are clearly associated with features of metabolic 
syndrome. A sedentary lifestyle (Laaksonen et al. 2002b, Lakka and Laaksonen 2007; 
Ilanne-Parikka et al. 2010), lower levels of cardiorespiratory fitness (Laaksonen et al. 
2002b; Hassinen et al. 2010), unhealthy diet (Laaksonen et al. 2005a), low socio-economic 
status (SES) (Brunner et al. 1997), low birth weight (Laaksonen et al. 2003) and depression 
(Viinamäki et al. 2009) are all related to obesity or metabolic syndrome. However, the time 
order of the associations and mediating factors underlying the associations are poorly un-
derstood. 
2.1.2 Definitions of metabolic syndrome  
The clustering of hypertension, hyperglycemia and gout was already recognized in the 
early 20th century (Zimmet et al. 2005), but it took almost a century to first attempt a global 
2 Review of literature 
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definition of metabolic syndrome (Zimmet et al. 2005). The different definitions of meta-
bolic syndrome are presented in Table 1. The World Health Organization (WHO) defini-
tion was published in 1999 (Alberti and Zimmet 1998). This definition included measure-
ment of insulin resistance by the euglycemic hyperinsulinemic clamp and was meant 
mainly for research purposes. The European Group for the Study of Insulin Resistance 
(EGIR) developed modified version of the WHO definition. The modified WHO definition 
(Laaksonen et al. 2002a; Lakka et al. 2002) includes hyperinsulinemia, impaired fasting 
glucose, or diabetes and the presence of at least two of the following: abdominal obesity 
(waist-to-hip ratio *WHR+ >0.90 or body mass index *BMI+ ≥30 kg/m2), dyslipidemia (trig-
lycerides ≥1.70 mmol/l or HDL cholesterol <0.9 mmol/l), or hypertension (blood pressure 
≥140/90 mmHg or blood pressure medication) (Alberti and Zimmet 1998). 
The National Cholesterol Education Panel (NCEP) published the Adult Treatment Pro-
gram III (ATPIII) definition two years later to improve the clinical diagnosis of metabolic 
syndrome. The NCEP definition for men includes three or more of the following: fasting 
blood glucose levels ≥5.6 mmol/l, triglycerides ≥1.7 mmol/l, HDL cholesterol <1.0mmol/l, 
blood pressure ≥130/85 mmHg, waist girth >102 cm (NCEP 2001; Laaksonen et al. 2002a).  
The International Diabetes Federation (IDF) published the definition in 2005, with an 
aim to identify people at high risk of CVD and diabetes throughout different ethnic 
groups. The IDF definition recognized that central obesity is a prerequisite for metabolic 
syndrome (Zimmet et al. 2005). In Europeans, the IDF definition is based on the following 
criteria: waist circumference ≥94cm in males and at least two of the following:  triglyce-
rides (≥1.7 mmol/l), HDL cholesterol (<1.0 mmol/l), blood pressure (systolic ≥130 mmHg or 
diastolic ≥85 mmHg) and fasting plasma glucose (≥5.6 mmol/l) (Zimmet et al. 2005).  
In recent years the IDF and the American Heart Association (AHA) have tried to unify a 
global definition for metabolic syndrome (Alberti et al. 2009). The newest update for the 
definition, released in 2009, uses the structure of the NCEP definition with the ethnic-
specific waist-girth parameters. A diagnosis comprises the presence of any three of the five 
risk factors. Therefore, abdominal obesity is one of the five criteria; not the prerequisite 
part of the syndrome. Defining abdominal obesity, however, still remains unresolved (Al-
berti et al. 2009). 
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Table 1 Definitions of metabolic syndrome 
 
NCEP IDF WHO (modified) c NHLBI/AHA 
≥3 of following 
Waist ≥94cma  
 
and ≥2 of following 
Insulin resistance॥,     
DM or IFG  
and ≥2 of following ≥3 of following 
Central obesity:  
waist  102cm 
Hypertriglyceridaemia: 
Triglycerides ≥1.7 
mmol/l 
Obesity: WHR  0.90 
or BMI  30 kg/m2 
Central obesity:  
waist ≥94 cma 
Hypertriglyceri-
daemia: Triglycerides 
≥1.7 mmol/l 
Low HDL-cholesterol: 
HDL 1.0 mmol/l 
Dyslipidaemia: Trigly-
cerides ≥ 1.7 mmol/l 
or HDL 0.9 
Hypertriglyceri-
daemia: Triglycerides 
≥1.7 mmol/l 
Low HDL-cholesterol:  
HDL 1.0 mmol/l 
Hypertension: Blood 
pressure ≥130/85 
mmHg or medication 
Hypertension: Blood 
pressure ≥ 140/90 
mmHg or medication 
Low HDL-cholesterol: 
HDL 1.0 mmol/l 
Hypertension:  
Blood pressure 
≥130/85mmHg or 
medication  
Fasting plasma glu-
cose ≥ 5.6 mmol/lbor 
DM  
 Hypertension: 
Blood pressure 
130/85mmHg or medi-
cation  
Fasting plasma glu-
cose ≥6.1 mmol/l 
  Fasting plasma glu-
cose ≥5.6 mmol/lb 
    
aEthnicity specific. bFasting blood glucose 5.0 mmol/l. cIn the original definition, microalbu-
minuria was also a criterion.  
NCEP = National Cholesterol Education Panel; IDF = International Diabetes Federation; WHO = 
World Health Organization; NHLBI = National Heart, Lung, and Blood Institute; AHA = Ameri-
can Heart Association; DM = Diabetes Mellitus; IFG = Impaired Fasting Glucose; WHR = 
Waist-to-hip ratio; BMI = Body Mass Index; HDL = High-density lipoprotein 
2.1.3 Public health importance of metabolic syndrome 
The prevalence of metabolic syndrome is rapidly increasing worldwide (Zimmet et al. 
2005). Metabolic syndrome forms a major public health issue by increasing the risk of type 
2 diabetes (Laaksonen et al. 2002a, 2004a) and CVD (Lakka et al. 2002). The global preva-
lence of diabetes is expected to double in the next two decades (IDF 2009). Diabetes will 
lead to approximately four million annual deaths globally in the age group of 20-79 (IDF 
2009). Meanwhile, worldwide health care expenditures caused by diabetes are estimated 
to be at least 376 billion U.S. Dollars in 2010 (IDF 2009). 
In Finland, the prevalence of overweight populations has been increasing (Helakorpi 
et al. 2005). As a consequence, in middle-aged and older Finns, up to 42% of men and 33% 
of women have impaired glucose tolerance or type 2 diabetes (Peltonen et al. 2006). Meta-
bolic syndrome usually precedes abnormalities in glucose metabolism, likely increasing 
the syndrome’s advancement.  
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2.2 PHYSICAL ACTIVITY 
2.2.1 Assessment of physical activity  
Physical activity has been defined as any bodily movement produced by skeletal muscles 
that increases energy expenditure beyond basal metabolic rate (Caspersen et al. 1985). A 
valid and reproducible assessment of physical activity is crucial in the investigation of re-
lationship between physical activity and health. Physical activity is multidimensional and 
no single method is able to capture all subcomponents and domains in the investigated 
activity (Warren et al. 2010). Frequency, duration and intensity are fundamental dimen-
sions of physical activity and allow calculation of energy expenditure associated with 
physical activity (Casparesen et al. 1985). Different types of physical activity exist, includ-
ing LTPA, commuting physical activity, lifestyle physical activity, occupational physical 
activity, conditioning physical activity, as well as recreational and competitive sports. 
Warren and coworkers recently published a review on the assessment of physical activi-
ty (Warren et al. 2010). They categorized the methods to assess free-living physical activity 
as self-reports (questionnaires, diaries, logs, recalls) and objective measures (motion sen-
sors such as accelerometers, pedometers, heart rate monitors, direct observation, doubly 
labeled water). In observational studies, physical activity is traditionally assessed using 
self-reports. The accuracy of these methods is complicated by reactivity, recall bias and 
social bias (Ainsworth and Levy 2004). Objective measurements have been developed to 
solve these issues. They are, however, often too expensive or unpractical to use in large 
population studies and have other issues such as difficulties in capturing nonambulatory 
movements correctly (Warren et al. 2010).  
Physical activity is typically classified by its intensity, expressed as metabolic equiva-
lent (MET). One MET, the basal rate of oxygen consumption, is defined as metabolic ex-
penditure at rest, corresponding to an oxygen uptake of 3.5 ml O2/kg and energy expendi-
ture of approximately 1 kcal/kg/hour.  Other activities can be expressed as multiples of 1 
MET: activities in range of 1.8-2.9 MET are considered low intensity activities, 3.0-5.9 MET 
moderate intensity and ≥ 6.0 MET vigorous (Warren et al. 2010). 
2.2.2 Assessment of cardiorespiratory fitness 
In population studies, cardiorespiratory fitness has been assessed by measuring maximal 
oxygen uptake (V02max), either directly by respiratory gas exchange analysis or indirectly in 
a graded exercise stress test (Åstrand and Rodahl 1986). Measuring V02max indirectly is 
based on the assumption of a linear relationship between heart rate and oxygen uptake 
and the extrapolation of a submaximal heart rate to a known or predicted maximal heart 
rate. Direct measurement of oxygen consumption is the most accurate method for assess-
ing cardiorespiratory fitness (Åstrand and Rodahl 1986). However, it is not often feasible 
or practical in large population studies. Therefore, indirect measurement of V02max has been 
applied more frequently in epidemiologic studies.  
2.2.3 Association between physical activity and cardiorespiratory fitness 
Cardiorespiratory fitness is closely related to physical activity. Physical fitness is mainly 
determined by the frequency, duration and intensity of physical activity (Laukkanen et al. 
2009) over the past weeks and months. However, the magnitude of response to exercise 
stimulus is genetically determined (Bouchard and Rankinen 2001; Blair et al. 2001). The 
direct genetic component of cardiorespiratory fitness is estimated to be 25% to 40% (Lauk-
kanen et al. 2009). Therefore, the associations of cardiorespiratory fitness with health out-
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comes should be estimated with caution when generalized to physical activity. Another 
distinction between cardiorespiratory fitness and physical activity is the intra-individual, 
day-to-day variability (Warren et al. 2010). Cardiorespiratory fitness stays relatively stable, 
taking time to adjust; whereas the level of physical activity constantly changes. Further-
more, V02max is typically measured objectively in observational studies; whereas the as-
sessment of physical activity is based on self-reports. This leads to a greater misclassifica-
tion of physical activity and often to a weaker association with health outcomes than those 
of physical fitness (Blair et al. 2001). 
2.2.4 Physical activity and general health 
Substantial evidence shows that physically active people are healthier and are less likely to 
develop many chronic diseases than people with a sedentary lifestyle. Lack of physical 
activity is a well-known risk factor for CVD and many other chronic diseases (Warburton 
et al. 2006). Regular exercise reduces blood pressure, systemic low-grade inflammation 
and adipose tissue, especially visceral fat, and enhances serum lipid profile, endothelial 
function, cardiac function, coronary blood flow, autonomic balance, insulin sensitivity and 
glucose homeostasis (Physical Activity Guidelines Advisory Committee Report, 2008). 
These health benefits of exercise lead to a reduced risk of type 2 diabetes, CVD, and pre-
mature death. Recent American guidelines recommend for all adults moderate physical 
activity 2.5 hours per week or one hour 15 minutes vigorous-intensity physical activity per 
week. Adults are also recommended to engage in muscle-strengthening activities on two 
or more says a week (Physical Activity Guidelines Advisory Committee Report, 2008). 
These guidelines were issued in Finland, as well (Physical Activity. Current Care guide-
line 2010). The guidelines are based on substantial systematic evidence. A total of 30 pros-
pective studies in 7 different countries, including >141 000 men and >263 00 women in 
gender-specific analysis and >50 00 subjects in analysis of both genders combined, showed 
a 30-35% risk reduction in the development of coronary heart disease (CHD) for most ac-
tive men and women (Physical Activity Guidelines Advisory Committee Report, 2008). 
Prospective studies published since the guidelines show similar results (Shiroma and Lee 
2010). Considering that most of these results have been controlled for beneficial effects of 
physical activity on cardiovascular risk factors, such as BMI, hypertension, dyslipidemia 
and diabetes, the risk reduction is probably underestimated (Shiroma and Lee 2010). 
The preventive effect of physical activity on the development of metabolic syndrome 
and type 2 diabetes is indisputable. In Kuopio Ischaemic Heart Disease Risk Factor (KIHD) 
study, physically active men were 48% less likely to develop metabolic syndrome than 
physically inactive men over four years (Laaksonen et al. 2002b). A review of randomized 
controlled trials (Williamson et al. 2004) showed a 40-60% reduction in the incidence of 
type 2 diabetes over 3-4 years in high risk individuals with a modest weight loss through 
diet and exercise. In the Finnish Diabetes Prevention Study regular physical activity was 
associated with a 57% reduced incidence of type 2 diabetes even after adjusting for dietary 
changes. In the Da Qing Impaired Glucose Tolerance and Diabetes Study (Pan et al. 1997), 
incident type 2 diabetes decreased by 46% in the exercise group, 42% in the diet and exer-
cise group, and 31% in the diet-treated group. The available evidence, although coming 
mostly from observational studies, strongly supports a causal relationship between in-
creased physical activity and health benefits. 
Importantly, the health benefits of regular physical activity exceed potential risks. The 
risk of sudden cardiac event is greater for people who stay inactive than for those who 
increase their physical activity (Warburton et al. 2006). The risk can be minimized by pre-
ferring moderate intensity physical activity and increasing the level of activity gradually. 
7 
 
Musculoskeletal injuries are the most common adverse events caused by physical activity 
(Aaltonen et al. 2007). The risk is highest in contact and team sports, ranging from 6.6 to 
18.3 per 1000 hours of participation and lowest in commuting and lifestyle activities and 
some sports such as golf, walking and swimming, ranging from 0.19 to 1.5 per 1000 hours 
of participation (Parkkari et al. 2004). The risk of overuse injuries can be decreased by pre-
ferring a variety of activities, increasing activity gradually and giving time for body adap-
tation (Aaltonen et al. 2007). 
2.2.5 Physical activity and mental health 
A physically active lifestyle contributes to mental health (Penedo and Dahn 2005). Obser-
vational studies have shown an inverse relationship of physical activity with various psy-
chological outcomes, including depressive symptoms, clinical depression and anxiety (Pe-
nedo and Dahn et al. 2005). However, wide variations in psychological variables and dis-
ease severity have lead to a wide diversity in outcome findings (Dunn 2009). The evidence 
on the psychological benefits of exercise comes mainly from over 100 observational stu-
dies, most of which have assessed a cross-sectional relationship between physical activity 
and depression (Ströhle 2008; Physical Activity Guidelines Advisory Committee Report, 
2008). These studies suggest that physically active people have on average a 45% lower 
odds of having depressive symptoms than physically inactive people (Physical Activity 
Guidelines Advisory Committee Report, 2008).  For instance, in American and Canadian 
population surveys among over 55,000 people, physical activity was associated with fewer 
depressive symptoms (Stephens 1988). In a study among over 16,000 participants from 15 
different European countries, physical activity was associated with improved mental 
health (Abu-Omar et al. 2004). Two large cohort studies of Finnish men and women 60 
years and over showed that lack of physical activity was associated with depressive symp-
toms (Kivelä and Pahkala 1991), and that intensive exercise was related to fewer depres-
sive symptoms (Ruuskanen and Ruoppila 1995). However, in the Kuopio Ischaemic Heart 
Disease Risk Factor (KIHD) Study, lower levels of cardiorespiratory fitness, rather than 
lower levels of physical activity, were associated with a higher risk of having depressive 
symptoms (Tolmunen et al. 2006).  
Prospective studies on physical activity and mental health are still scarce. The Caerphil-
ly Study found no relationship, after ten years, between leisure-time physical activity and 
incident of common mental disorders (Wiles et al. 2007). Neither did physical exercise 
predict a depression score, eight years after commencement, in the Rancho Bernardo 
Study (Kritz-Silverstein et al. 2001). In The Harvard Alumni Study, however, physically 
active men had lower depression rates over a 25-year follow-up time (Paffenbarger et al. 
1994). The Alameda County study also showed that lack of physical activity predicted the 
development of depression five years later (Camacho et al. 1991). Other studies including 
only women or adolescents have shown similar results (Motl et al. 2004; Wise et al. 2006; 
Ströhle et al. 2007). The evidence supporting the American physical activity guidelines 
includes 28 prospective studies in nearly 40 000 adults from 11 nations with follow-up 
time ranging from 9 months to 37 years (Physical Activity Guidelines Advisory Commit-
tee Report, 2008). This review concluded that the odds of developing depressive symp-
toms was 15 to 25% lower among physically active than inactive people after adjustment 
for the risk factors of depression. Some studies used a clinical diagnosis to define depres-
sion, indicating that the association of physical activity with depression is not limited to 
self-reported symptoms of depression. Furthermore, this inverse association between 
physical activity and depression was independent of age, sex, ethnicity and medical condi-
tion (Physical Activity Guidelines Advisory Committee Report, 2008). 
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Existing evidence makes it tempting to believe the causal effect of physical activity on 
depressive symptoms. De Moor and colleagues investigated 8662 twins (of whom 2743 
were identical) and their parents in a prospective study and reported common genetic fac-
tors explaining a lack of voluntary physical activity with a risk for depression and anxiety 
(De Moor et al. 2008). The authors caution against justifying exercise as treatment of de-
pression without randomized-controlled trials. The finding of the study, however, does 
not exclude the possibility that physical activity may prevent and reduce symptoms of 
depression and have other beneficial effects on mental health. 
Experimental studies have shown that exercise decreases symptoms of depression 
(Lawlor and Hopker 2001; Dunn et al. 2005; Dunn 2009). Blumenthal and colleagues 
showed in a randomized controlled trial that the magnitude of the effect of exercise is 
comparable to that of an antidepressant (Blumenthal et al. 1999). A controlled trial by 
Dunn and colleagues reported a 40 to 50% better response and remission rates in the exer-
cise training group compared to the social interaction and sunlight exposure place groups. 
A recent comprehensive Cochrane review with a meta-analysis of 25 randomized con-
trolled trials comparing exercise to standard treatment, no treatment or placebo in adults 
with depression, showed that exercise decreased symptoms of depression (Mead et al. 
2009). However, the authors were unable to determine the magnitude of the effect of exer-
cise and the most effective type of exercise. There was no difference in the magnitude of 
the effect of exercise and other interventions, such as antidepressants and psychotherapy. 
Although, evidence on the intensity of physical activity needed for the treatment of de-
pression is limited, the American Physical Activity Guidelines Advisory Committee (2008) 
concluded that both moderate-intensity and vigorous physical activity equally protect 
against depressive symptoms compared to low intensity physical activity. Moreover, the 
committee concluded that any physical activity is better than physical inactivity. The pro-
tective effect of physical activity is independent of the mode and length of the exercise 
program. Furthermore, an increase in physical fitness is not required to reduce depressive 
symptoms. 
Mechanisms underlying the relationship of physical activity with mental health are still 
unclear. Regular physical activity, certainly, has positive effects on several psychosocial 
factors, including self-esteem and self-efficacy, social isolation, self-image and self-worth 
(Camacho et al. 1991), distraction, a sense of mastery and self-concept (Ströhle 2008). Fur-
thermore, physical activity is suggested to have positive influences on brain structure and 
function in humans (Dishman et al. 2006). The mechanisms behind these adaptations are 
not known, but several neurogenerative, neuroadaptive and neuroprotective processes 
have been suggested in animal models, including increased expression of brain growth 
factors, stimulation of growth and development of brain cells and protection from neuro-
toxic damage (Dishman et al. 2006). Other possible biological pathways include activation 
of the hypothalamic-pituitary-adrenocortical system (Ströhle and Holsboer 2003), in-
creased neurotransmissions of central dopaminergic, noradrenergic and serotonergic sys-
tems (Meeusen and De Meirleir 1995), as well as increased biosynthesis of neurotransmit-
ters, such as monoamines, catecholamines and endorphines (Wise et al. 2006).  
Furthermore, depression has been associated with an increased release of inflammatory 
cytokines (IL-1, IL-2, IL-6, TNF-alpha) (Smith 1991; Shimbo et al. 2005). IL-6 induces the 
production of C-reactive protein (CRP), which has been related to depression (Smith 1991; 
Liukkonen et al. 2006). Acute physically activity is a well-known activator of inflammatory 
system, increasing the release of IL-6 from muscle up to 100-fold during exercise (Pedersen 
et al. 2003). Interestingly, the effects of such response seem to be anti-inflammatory and to 
improve lipid and glucose metabolism. In long run, regular physical activity can lead to 
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lower basal levels of inflammatory cytokines in circulation (Lakka et al. 2005; Beavers et al. 
2010). How this relates to depressive symptoms is not known.  
2.3 DEPRESSIVENESS AND HOPELESSNESS 
2.3.1 Assessment of depressive symptoms 
Depressive symptoms refer to wide range of mental problems, including emotional, cogni-
tive, behavioral and physical symptoms. Most epidemiological studies use self-report 
questionnaires to assess depressive symptoms and to identify persons with perceived 
mental stress. Self-reports are less expensive and less time-consuming than interviews and 
therefore more practical for research use. The Beck Depression Inventory (BDI) and the 
Center for Epidemiologic Studies Depression Scale (CES-D) are the most widely used de-
pression scales (Van Dam and Earleywine 2010). Depression scales are intended as screen-
ing instruments to identify individuals likely to have psychopathology rather than as spe-
cific diagnostic tools. These scales can also be used to provide quantitive assessment of 
depressive symptoms.  
Assessment of depressive symptoms is complex. For many constructs in psychiatry, 
there is no absolute truth (Blacker and Endicott 2008). All self-report measures are suscept-
ible to the questions of validity since individuals may exaggerate or minimize their degree 
of distress (Delman et al. 2008). Nevertheless, some measures give more valuable data 
than others. Data obtained from questionnaires have claimed to have weak associations 
with clinical diagnosis of depression and stress (Fechener-Bates et al. 1994). Questionnaires 
are, however, designed to measure several dimensions of psychopathology and functional 
behavior and to assess mental health among healthy individuals and to provide screening 
for symptoms of psychopathology in general populations. 
2.3.2 Depressiveness in relation to physical health 
Depression has become a leading cause of disability in the western world (Lopez and 
Mathers 2006). The lifetime prevalence of depression is estimated to be 10-15% in devel-
oped countries. Depression not only deteriorates subjective well-being but also weakens 
physical health. Depression has been implicated in the development of cardiovascular dis-
ease and all-cause mortality (Lett et al. 2004; Van der Kooy et al. 2007). According to a sys-
tematic meta-analysis by Van der Kooy and coworkers (2007) including 28 longitudinal 
and case-control studies with approximately 80 000 subjects, a depressed mood was mod-
erately associated with an increased risk of myocardial infarction (MI), coronary heart dis-
ease, cerebrovascular diseases and other cardiovascular diseases. This evidence, however, 
suffers from heterogeneity, and only overall combined risk of depression for the onset of 
MI was homogenous. A clinically diagnosed major depression had the strongest associa-
tion with the risk of CVD that was equal to the risk of smoking and diabetes (Van der 
Kooy et al. 2007).  
Depression is also related to metabolic disorders. The association of depression with 
obesity (Luppino et al. 2010), insulin resistance (Timonen et al. 2005), metabolic syndrome 
(Viinamäki et al. 2009) and type 2 diabetes (Knol et al. 2006) have all been reported. A 
large meta-analysis showed that depressed persons had a 58% higher risk of developing 
obesity than those without depression (Luppino et al. 2010). The authors argued that de-
pression had a stronger association with obesity than with overweight indicating a dose-
response gradient in the association. Räikkönen and colleagues (2007) reported that wom-
en with high levels of depressive symptoms were at an increased risk of developing meta-
bolic syndrome. A meta-analysis of nine longitudinal studies showed that adults with de-
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pression or higher levels of depressive symptoms have a 37% higher risk of developing 
type 2 diabetes compared to those with lower levels of depressive symptoms (Knol et al. 
2006). 
Accumulating evidence supports the argument that emotional stress is the third key 
factor causing the obesity epidemic and the following outcomes, after “the big 2” (too 
much food, too little exercise) (Cuzza and Rother 2011). The mechanisms explaining the 
mind-body interrelations remain unclear. Several plausible factors may, however, mediate 
associations of depression with cardiovascular and metabolic health, including lifestyle, 
psychosocial, physiological and pharmacological factors. Depressed persons are more like-
ly to follow an unhealthy lifestyle, such as physical inactivity and overeating, and there-
fore gain unfavorable health outcomes (Blumenthal et al. 1982). Van Oudenhove et al. 
(2011) recently published an interesting discovery: Sad emotions, assessed by neuroimag-
ing, can be modified by food intake without the sense of taste, sight and smell. Fatty and 
salty food, given by an intragastric infusion, decreased sad emotions and experimentally 
induced sadness increased hunger. Not only do people seek comfort food to alleviate dis-
tress, but the intestinal system itself is capable of modulating the brain’s activity. Mind-
body-behavior interactions are fascinating and yet to be revealed. 
Neuroendocine and neuroimmune interactions may also explain the associations of de-
pression, CVD and obesity. Neuroendocrinological studies of depression show that both 
metabolic syndrome and depression are associated with an increased activity of the hypo-
thalamus-pituitary-adrenal (HPA) system and elevated glucocorticoid concentrations, 
which promote accumulation of visceral fat (Björntorp 2001). A hyperactive HPA axis is 
found in 75% of patients with major depression (Ahlberg et al. 2002). This hyperactivity 
may lead to hypercortisolaemia and increase accumulation of visceral fat (Weber-Hamann 
et al. 2002). A study by Vogelzangs and co-workers (2007) suggests that hyperactivity of 
HPA axis indentifies a specific subtype of depression that is related to metabolic syn-
drome, mediated by central obesity. Although cortisol is an anti-inflammatory hormone, 
there is evidence that in depressed patients cortisol fails to inhibit inflammatory responses 
by insufficient glucocorticoid signaling, called glucocorticoid resistance (Pace and Miller 
2009). Inflammatory cytokines not only activate the HPA axis (Miller et al. 2009) but also 
independently stimulate the adrenal gland to secrete cortisol (Bornstein et al. 2008). Corti-
sol may initiate and worsen depressive symptoms (Howren et al. 2009). Depression could 
increase low-grade inflammation through decreasing parasympathetic activity (Howren et 
al. 2009). Inflammation, in turn, upregulates the HPA axis by increasing the release of cor-
ticotrophin-releasing hormone (CRH) (Howren et al. 2009). Hypothetically, this process 
may lead to vicious circle where central nervous system connects depression to systemic 
low-grade inflammation and vice versa. Ultimately this synergistic effect could result in 
unfavorable cardiovascular and metabolic outcomes. 
Depression, obesity and cardiovascular diseases tend to cluster and observational stu-
dies indicate the link between them. Reduction of stress control often predisposes one to 
clinical depression, whereas lifestyle factors, such as physical activity and healthy diet, 
enhance coping with stress. More evidence is critically needed to fully understand the as-
sociations between these highly prevalent public health concerns. Whether some depres-
sive symptoms relate more strongly than others to physical health is also undetermined. 
2.3.3 Hopelessness – facet of depression or distinct entity? 
Hopelessness, a major symptom of depression, has been determined as a system of nega-
tive expectancies concerning oneself and one’s future (Stotland 1969). Hope is an impor-
tant determinant of subjective well-being (Stotland 1969). Lack of hope is associated with 
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various manifestations of psychological morbidity (Haatainen et al. 2004). Psychological 
factors associated with hopelessness in the general population include depression, suicidal 
ideation and alexithymia, meaning a poor ability to recognize and verbalize emotions and 
externally oriented way of thinking (Haatainen et al. 2004). Some studies suggest that 
hopelessness might be even a more powerful risk factor of suicidality than depression 
(Beck et al. 1993, Salter and Platt 1990). Hopelessness has been seen as a trait that reflects 
person’s attitude and increases vulnerability to react to certain environmental stimuli with 
depression (Henkel et al. 2002). These stimuli include unemployment, poor financial situa-
tion (Haatainen et al. 2003b), poor general health, dissatisfaction with life (Haatainen et al. 
2004) and stress (Northouse et al. 2001), which all are associated with hopelessness in gen-
eral populations. 
Hopelessness has also been demonstrated to have a negative impact on physical health 
(Scheier and Carver 1985) and mortality (Stern et al. 2001).  Everson and co-workers have 
shown that hopelessness is significantly associated with the incidence of hypertension, 
myocardial infarction, and cardiovascular mortality and with accelerated progression of 
carotid atherosclerosis in middle-aged men (Everson et al. 1996, 1997, 2000). In women, 
hopelessness was a strong and independent risk factor for subclinical atherosclerosis 
(Whipple et al. 2009). The National Health Examination Follow-up Survey also showed the 
relationship between hopelessness and the incidence of fatal and non-fatal ischemic heart 
disease during a 12-year follow-up (Anda et al. 1997). Recently, hopelessness was reported 
to associate with plasma levels of soluble intercellular adhesion molecule-1 (s-ICAM1) and 
e-selectin, that are adhesion molecules thought to be early markers of endothelial dysfunc-
tion (Do et al. 2010). Of interest, in all of these studies the association of hopelessness with 
the outcomes was stronger than that of depression. 
Hopelessness is rather common in general populations. According to Haatainen and 
colleagues (2003a) the prevalence of hopelessness measured with the Beck Hopelessness 
Scale in a homogenous sample of Finnish adults was 11.4%. Hopelessness is often a major 
symptom of depression. However, after excluding those with any self-reported mental 
disorder diagnosed or treated by a physician during the preceding year the prevalence of 
hopelessness was still as high as 7.8%. Thus, although feelings of hopelessness and futility 
are common features of depression, hopelessness often exists in the absence of depression. 
Hopelessness has also been shown to have independent association with 5-HTTLPR s al-
lele, proposing that hopelessness may be a distinct phenotype from depression (Kangelaris 
et al. 2010). Previous studies (Everson et al. 1996, 1997, 2000; Anda et al. 1997; Do et al. 
2010) suggest that the correlation between hopelessness and depression scales is only 
moderate. Moreover, these studies suggest that the associations of feelings of hopelessness 
and depression can be disentangled, and that hopelessness may be a more powerful pre-
dictor of adverse cardiovascular outcome than depressive symptoms. Thus, although 
hopelessness is a facet of depression, it is nonetheless a distinct entity. 
2.4 SYSTEMIC LOW-GRADE INFLAMMATION – COMMON SOIL HYPO-
THESIS 
Systemic low-grade inflammation has been implicated as part of the “common soil” 
leading to development of metabolic syndrome, type 2 diabetes and cardiovascular dis-
ease (Laaksonen et al. 2004b, 2005b, Mathieu et al. 2010). C-reactive protein, an acute phase 
protein delivered from the liver, rises in concentration as a response to infection or any 
tissue injury. This protein is also an important marker of systemic low-grade inflamma-
tion. According to the Centers for Disease Control and American Heart Association, 
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people with plasma levels of CRP over 3.0mg/l have a 2-fold risk of CVD compared with 
those with CRP levels below 1mg/l (Williamson et al. 2004). The KIHD Study showed that 
middle-aged men with plasma levels of CRP above 3mg/l had an increased risk of devel-
oping metabolic syndrome and type 2 diabetes during 11 years of follow-up than those 
with CRP levels below 1 mg/l (Laaksonen et al. 2004b). In addition, empirical evidence 
links low-grade inflammation to several other diseases, such as dementia, chronic, ob-
structive pulmonary disease, osteoporosis, arthritis, heart failure and cancer (Beavers et al. 
2010). 
Cross-sectional studies have shown that depression is linked with an increased release 
of inflammatory cytokines, and obesity may in part mediate the association (Howren et al. 
2009). In previous studies, low-grade inflammation has been suggested to be the common 
denominator between depressive symptoms and cardiovascular and metabolic outcomes. 
Pollitt and coworkers (2005) reported that fibrinogen, a systemic marker of inflammation 
and thrombosis, partly mediated the relationship between hopelessness and the progres-
sion of carotid atherosclerosis. Frasure-Smith et al. (2007) followed patients with acute co-
ronary syndromes for two years and found that depressive symptoms and plasma levels 
of CRP were associated with an increased risk of major adverse cardiac events but the 
combined effect was not additive. Only men with both low levels of CRP and no depres-
sion had a low risk of cardiac events, suggesting that CRP and depression are at least par-
tially overlapping risk factors. On the other hand, a study by Ladwig and coworkers 
(2005) suggested that depressive mood increases the power of low-grade inflammation to 
predict myocardial infarction. Other studies also reported that inflammation did not ex-
plain the relationship between depressive symptoms and CVD incidence (Empana et al. 
2005; Vaccarino et al. 2007; Nabi et al. 2010).  
The few studies on depression, low-grade inflammation and obesity are cross-sectional. 
Ladwig and coworkers (2003) found a relationship between depressive mood and plasma 
CRP levels in obese but not in non-obese men. However, Olszanecka-Glinianowicz and 
colleagues (2009) did not observe differences in inflammatory markers between depressive 
and non-depressive patients with obesity. This finding could be explained by a very high 
BMI of all subjects and a small study population. Capuron and coworkers (2008) investi-
gated the role of inflammation in the association of depressive symptoms with metabolic 
syndrome in 323 men. The cross-sectional relationship of neurovegetative depressive 
symptoms and metabolic syndrome was weakened after adjusting for CRP and IL-6, sug-
gesting that inflammation mediates, in part, this association. A recently published review 
assessed the direction of the association between depression and inflammatory markers 
and suggested that the direct association could be the result of a complex, tridirectional 
relationship among adiposity, low-grade inflammation and depression (Howren et al. 
2009).  
Evidently, long term exposure to systemic low-grade inflammation may lead to the de-
velopment of chronic diseases. The evidence explaining the nature of this relationship is 
limited. It is, however, hypothesized that behavioral interventions that control or reduce 
low-grade inflammation could be effective to prevent and treat chronic disease. Physical 
activity has been shown to be related to lower levels of inflammation in observational stu-
dies (Nicklas et al. 2005; Beavers et al. 2010). Promising data from randomized control tri-
als exists as well, indicating that aerobic physical activity may be beneficial in reducing 
low-grade inflammation, especially for people with elevated inflammatory markers (Beav-
ers et al. 2010). 
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2.5 SUMMARY OF THE REVIEWED LITERATURE 
Metabolic syndrome forms a major concern for public health by predisposing people to 
type 2 diabetes and cardiovascular diseases. Depressive symptoms, such as hopelessness, 
also deteriorate physical health. Based on the reviewed literature, the association between 
metabolic syndrome and depression is very complex. Several behavioral, physiological 
and social factors may explain relationship between them. Systemic low-grade inflamma-
tion may provide “the common soil” in the development of several chronic diseases. 
However, understanding of mediating factors and the causality in the relationship be-
tween metabolic syndrome and depression is largely lacking. Whether some depressive 
symptoms are more harmful for metabolic health than the others is also unknown. Hope-
lessness, defined as system of negative expectations concerning oneself and one’s future, 
has been shown to increase risk for cardiovascular morbidity and mortality, independent 
of depression. Some studies argue that hopelessness is more powerful risk factor for CVD 
than depression. Although hopelessness and depression overlap, they are still considered 
distinct phenomena. How feelings of hopelessness relate to metabolic syndrome has not 
been studied earlier. 
Physical activity clearly has positive effects on both physical and mental health. Sub-
stantial evidence shows that physically active people are less likely to develop symptoms 
of depression than people with sedentary behavior. In addition, intervention studies re-
port antidepressive effects of exercise. Majority of the existing data, however, are criticized 
to have methodological deficiencies. More prospective data is called for to further distin-
guish the association of physical activity with depression and depressive symptoms.  
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The purpose of the doctoral thesis is to provide new information about the etiology of me-
tabolic syndrome, depression and hopelessness, to disentangle their relationships, and to 
clarify possible mediating factors underlying the associations. The Kuopio Ischemic Heart 
Disease Risk Factor Study (KIHD) with its large database and long follow-up period of-
fered a unique opportunity to study cross-sectional and longitudinal relations of psy-
chosocial factors and metabolic syndrome. The aims of the study were to answer the fol-
lowing specific questions in middle-aged men: 
 
1. Are depressive symptoms and hopelessness associated with metabolic syndrome, 
and what are the determinants of this association? (Study I) 
2. Do psychosocial risk factors predict the development of metabolic syndrome and 
what are the mediating mechanisms of this association (e.g. life-style factors, mark-
ers of systemic low-grade inflammation)? (Study II) 
3. Do higher levels of physical activity and cardiorespiratory fitness protect against 
the development of depressive symptoms and hopelessness? (Study III and IV)? 
3 Aims of the study 
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4.1 STUDY POPULATION 
The Kuopio Ischemic Heart Disease Risk Factor Study (KIHD) is a population-based, co-
hort study that was designed to investigate biological, behavioral, socioeconomic and psy-
chosocial risk factors for ischemic heart disease, diabetes and related outcomes in a sample 
of middle-aged men in Eastern Finland (Salonen 1988). Baseline data were collected be-
tween 1984 and 1989 from 2682 (89.2% of those eligible) male participants aged 42, 48, 54 
and 60 years old. This study group is a representative sample of Finnish male population 
from town of Kuopio and neighboring rural communities. For the KIHD 4-year and 11-
year follow-up study, 1229 subjects who had undergone carotid ultrasound examination at 
baseline between 1987 and 1989 were eligible. Of these, 1038 underwent repeat examina-
tions during 1991-1993 and 854 during 1998–2001 (Lakka et al 2001). 
The Research Ethics Committee of the University of Kuopio approved the study. All 
study subjects gave their written informed consent. The different studies include approx-
imately from 500 to 2500 men who had complete data on the main characteristics of meta-
bolic syndrome and who completed questionnaires on depressive symptoms and physical 
activity. The participants who had complete data on all study variables were eligible for 
the present study. The study samples and designs are presented in Table 2. 
4 Materials and methods 
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Table 2. Description of the study populations and designs. 
 
Study Design Size Exclusions at base-
line 
Variable of interest Main outcome 
I cross-
sectional 
 
1743 diabetes Hopelessness Metabolic syndro-
me 
II a 11-year 
follow-up 
726 diabetes,  
waist >102cm  
 
Depressive symp-
toms, low-grade in-
flammation 
waist >102cm 
II b 11-year 
follow-up 
689 diabetes,  
metabolic syndrome 
Depressive symp-
toms, low-grade in-
flammation 
Metabolic syndro-
me 
III cross-
sectional 
2428 none  
 
Physical activity, 
cardiorespiratory 
fitness 
Hopelessness 
IV a 4-year fol-
low-up 
630 hopelessness  
 
Physical activity Hopelessness  
IV b 11-year 
follow-up 
509 hopelessness  
 
Physical activity Hopelessness 
 
4.2 DEFINITION OF METABOLIC SYNDROME 
In the present study definitions of metabolic syndrome were used as proposed by the 
World Health Organization (WHO), the National Cholesterol Education Program (NCEP) 
and the International Diabetes Federation (IDF).  The criteria of these definitions are pre-
sented previously in detail (Table 1). When using WHO definition, insulin resistance was 
estimated based on the upper quartile of fasting insulin concentrations (Lakka et al. 2002). 
Impaired fasting glucose was defined as a fasting blood glucose 5.6-6.0 mmol/l, equivalent 
to plasma glucose of 6.1-6.9 mmol/l (Alberti and Zimmet 1998).  Diabetes was determined 
as fasting blood glucose concentration 6.1 mmol/l (equivalent to plasma glucose 7.0 
mmol/l) or a clinical diagnosis of diabetes with either dietary, oral or insulin treatment 
(Laaksonen et al. 2002a; Lakka et al. 2002).  Waist circumference cut-offs were used as >102 
cm for NCEP definition and 94cm for IDF definition. 
 
4.3 ASSESSMENT OF COMPONENTS AND FEATURES RELATED TO META-
BOLIC SYNDROME  
Body mass index was computed as the ratio of weight to the square of height (kg/m2). 
WHR was defined as waist girth/hip circumference measured at the trochanter major. 
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Waist circumference was calculated as the average of two measurements taken at the mid-
point between the lowest rib and the iliac crest after inspiration and expiration. Resting 
blood pressure was measured between 8 and 10 o’clock by two trained nurses with a ran-
dom-zero mercury sphygmomanometer (Hawksley, Lancing, UK). 
Fasting blood glucose was measured using a glucose dehydrogenase method after pre-
cipitation of proteins by trichloroacetic acid. Serum insulin was determined with a Novo 
Biolabs radioimmunoassay kit (Novo Nordisk, Bagsvaerd, Denmark). Plasma fibrinogen 
was measured based on the clotting of diluted plasma with excess thrombin. Serum high 
sensitivity C.reactive protein (hs-CRP) was measured with an immunometric assay (Im-
mulite High Sensitivity C-reactive protein Assay, DPC, Los Angeles, CA, USA) (Laaksonen 
et al. 2004b). This C-reactive protein assay has been standardized against the WHO 
International Reference Standard for C-reactive protein Immunoassay 85/506. At the level 
of 3.2 mg/L, the within-run CV is 2.8% and the total CV is 3.1% (Laaksonen et al. 2005b). 
4.4 ASSESSMENT OF PHYSICAL ACTIVITY 
The validated KIHD 12-month LTPA Questionnaire was used in the present study to as-
sess physical activity (Lakka and Salonen 1992; Lakka et al. 1994). This is a detailed quanti-
tative questionnaire assessing the duration, frequency and mean intensity of the most 
common lifestyle and structured LTPA of middle-aged Finnish men as recalled over the 
previous 12 months. Physical activity was categorised according to type: 1) conditioning 
physical activity: walking, jogging, cross-country skiing, bicycling, swimming, rowing, 
ball games and gymnastics, dancing or weight lifting, 2) nonconditioning physical activity: 
crafts, repairs or building, yard work, gardening, farming or snow shovelling, hunting, 
picking berries or gathering mushrooms, fishing and forest work or forestry, 3) walking or 
cycling to work. Low-intensity LTPA was defined as <4.5 METs, moderate-to-vigorous 
LTPA as ≥4.5 METs and vigorous LTPA as ≥7.5 METs. The durations of LTPA were calcu-
lated in min/week. 
 
4.5 ASSESSMENT OF CARDIORESPIRATORY FITNESS 
A graded symptom-limited exercise test was performed on an electrically braked cycle 
ergometer (Tunturi EL 400 bicycle ergometer, Turku, Finland). Oxygen consumption was 
measured by respiratory gas analysis using either the mixing–chamber method 
(Mijnhardt, Odijk, the Netherlands) or the breath-by-breath method (Medical Graphics, St. 
Paul; MN, USA) as previously described in detail (Lakka et al. 1994, 2001). V02maxwas de-
fined as the highest value for or the plateau in oxygen uptake. 
4.6 ASSESSMENT OF DEPRESSIVE SYMPTOMS 
The Human Population Laboratory Depression Scale (HPL Depression Scale) was used to 
assess depressive symptoms. The HPL Depression Scale is a self-administered question-
naire that includes 18 items on conditions related to  depression such as mood distur-
bances, a negative self-concept, loss of energy, problems with eating and sleeping, diffi-
culty in concentrating, and psychomotor retardation or agitation (Roberts and O’Keefe 
1981; Kaplan et al. 1987; Tolmunen et al. 2004a, 2004b, 2006). The score is generated by as-
signing one point for each true or false answer that corresponds to depressive symptoms. 
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The range of the HPL Depression Scale is 0-18 points. This scale has good internal consis-
tency and demonstrated reliability (Kaplan et al. 1987) and it was specifically developed 
for screening general population samples (Roberts and O’Keefe 1981; Kaplan et al. 1987). 
A cut-off ≥5 has been used previously to classify men with depressive symptoms and to   
define clinically significant depression (Kaplan et al. 1987). The same cut-off point was 
used in the present thesis.  
4.7 ASSESSMENT OF HOPELESSNESS 
The subjects filled in several psychological questionnaires at baseline, at 4-year and 11-
year follow-ups. The questionnaires included two items that measured hopelessness 
(Everson et al. 1996, 1997, 2000). These items were “the future seems to be hopeless, and I 
cannot believe that things are changing the better” and “I feel that it is impossible to reach 
the goal I would like to strive for”. Participant responded using 5-point Likert scale (0 = 
absolutely agree, 1 = somewhat agree, 2 = cannot say, 3 = somewhat disagree, or 4 = abso-
lutely disagree). Hopelessness score, with a range of 0 to 8, was created by reverse-coding 
and summing the items.  The items were moderately correlated (r = 0.53) and the mean SD 
for hopelessness score at baseline was 2.73 (2.0). Cronbach’s alpha for hopelessness score 
was 0.70. Scores on the hopelessness scale increased with age (P<0.001, means varied from 
2.02 for 42-year olds to 2.93 for 54- and 60-year-olds) (Everson et al. 1996). 
4.8 OTHER ASSESSMENTS 
Participants filled in self-administered standardised questionnaires at baseline to record 
their medical history, adult socioeconomic status and lifestyle factors, such as smoking 
habits and alcohol consumption. Information on the amount of cigarettes, cigars and pipe-
fulls of tobacco were ascertained by questionnaire. Smoking was categorized as none, 1 – 
20 cigarettes/day or more than 20 cigarettes/day. A questionnaire on the quantity, fre-
quency and type of alcoholic beverages was used to estimate alcohol intake. The average 
weekly consumption of alcohol was measured in pure ethanol (g/wk) (Kauhanen et al. 
1997). Adult socioeconomic status was estimated using a summary index based on data 
collected by questionnaire on income, education, housing tenure and ownership of mate-
rial goods (Lynch et al. 1994). The index ranged from 1 to 10, a higher value indicating 
lower socioeconomic status.  
4.9 STATISTICS 
SPSS 11.0-14.0 for Windows (SPSS, Inc., Chicago, IL) was used to perform all statistical 
analyses. Statistical significance was considered to be P<0.05. 
 
Study I. Men were categorized into tertiles based on the scores for hopelessness. Differ-
ences in clinical and biochemical characteristics between men in hopelessness categories 
were tested for statistical significance with one-way ANOVA, and where indicated, the 
chi-squared test. The cut-off for the second tertile was 2 points and for the highest tertile 4 
points. The associations of hopelessness with metabolic syndrome were estimated using 
logistic regression models adjusting for covariates.  
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Study II. Abdominal obesity was defined as waist girth >102cm and this was considered 
as endpoint at 11-year follow-up. To study the risk of developing abdominal obesity and 
metabolic syndrome, men with waist girth above the cut-off or men with metabolic syn-
drome at baseline were excluded from the prospective analyses.  Men with diabetes and 
those using antidepressants were also excluded from these analyses. 
Differences in characteristics between men who developed central obesity during the 
11-year follow-up and those who did not were assessed with Student's t-test for continu-
ous variables and the chi-squared test for categorical variables. A variable combining low-
grade inflammation and depressive symptoms was created using the cut-offs serum hs-
CRP ≥2mg/l and HPL Depression Scale ≥5 points. Participants were categorized into three 
groups according to these scores: men with no inflammation nor depressive symptoms, 
men with either inflammation or depressive symptoms and men with both inflammation 
and depressive symptoms. The association between low-grade inflammation and depres-
sive symptoms and the risk of developing abdominal obesity at 11-year follow-up was 
estimated using logistic regression analysis adjusting for covariates. In separate analysis, 
the associations of low-grade inflammation and the risk of developing abdominal obesity, 
as well as depressive symptoms and the risk of developing abdominal obesity were tested. 
Variables with skewed distributions are presented as medians (interquartile ranges) and 
analysed using log-transformed values. Other data are presented as means ± standard de-
viations or percentages. 
 
Study III. Participants were categorized by tertiles based on their scores for hopelessness. 
Differences between men in the highest third of hopelessness and men in the middle and 
lower thirds were assessed with one-way ANOVA, and where indicated, the chi-squared 
test. LTPA and VO2max were categorized by tertiles for logistic regression analyses. The 
associations of LTPA and VO2max with hopelessness were estimated using logistic regres-
sion models adjusting for age, smoking, alcohol consumption, presence of CVD, adult SES, 
low-grade inflammation, BMI and depressive symptoms. Durations of LTPA (in 
min/week) and triglyceride, insulin and hs-CRP concentrations are presented as medians 
(interquartile ranges); other data are presented as means ± SD or simple percentages. 
Triglyceride and insulin concentrations were corrected for skewing using log transforma-
tion for statistical analysis but are presented using untransformed values.  
 
Study IV. At baseline men with a hopelessness score in the highest tertile, i.e. those with ≥ 
4 points were excluded from the prospective analyses. Men who scored ≥ 4 points after 
follow-up were defined as having developed hopelessness. Differences in characteristics at 
baseline between men who developed hopelessness during the 11-year follow-up and 
those who did not were assessed with Student's t-test for continuous variables and the chi-
squared test for categorical variables. The association between LTPA and risk of develop-
ing hopelessness at the 4- and 11-year follow-up was estimated using logistic regression 
analysis adjusting for covariates. Variables with skewed distributions are presented as 
medians (interquartile ranges) and analysed using log-transformed values. Other data are 
presented as means ± standard deviations or simple percentages.  
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5.1 HOPELESSNESS AND METABOLIC SYNDROME (Study I) 
Baseline clinical characteristics. Men in the highest third of hopelessness were physically 
less active, had lower socio-economic status and more commonly smoked than other par-
ticipants (Table 2 of the Original Publications, Study I). They also had a higher BMI, larger 
waist girth and higher mean systolic blood pressure. The participants in the highest third 
had also higher CRP concentrations than the other men. The prevalence of metabolic syn-
drome as defined by the NCEP and the IDF increased in a graded fashion across hopeless-
ness categories. The prevalence of elevated depressive symptoms also increased gradually 
with the hopelessness categories.  
 
Hopelessness and metabolic syndrome. Men in the highest third of hopelessness were 2.2 
times more likely to have metabolic syndrome by NCEP definition than men in the lowest 
category in models adjusting for age (Table 3 of the Original Publications, Study I, 
P<0.001). After further adjustment for traditional risk factors (SES, presence of CVD, smok-
ing, alcohol consumption, physical activity) and BMI, the association remained statistically 
significant (P=0.002-0.009). After further adjustment for traditional risk factors and sepa-
rate components of metabolic syndrome the association still persisted (e.g. plasma glucose 
P=0.002, serum insulin P=0.004, waist girth P=0.017).  
Adjustment for traditional risk factors and adult socioeconomic position did not alter 
the association (upper vs. lower third, OR 2.1, 95% CI 1.3-3.2). Adjustment for other meas-
ures of socioeconomic status, such as income and years of education, also did not change 
the observed association between hopelessness and metabolic syndrome (data not shown). 
Concentrations of serum CRP and plasma fibrinogen were also higher in men with 
more pronounced feelings of hopelessness. Adjustment for CRP and fibrinogen, however, 
did not alter the association of hopelessness with metabolic syndrome (data not shown). 
The analysis by the IDF definition of metabolic syndrome showed similar results, but 
the association was somewhat weaker. The risk to have metabolic syndrome was 1.6 times 
higher for the men in the highest group than men in the lowest group of hopelessness after 
adjustment for age (Table 3 of the Original Publications, Study I, P=0.002). Adjustment for 
the traditional risk factors and BMI decreased this association slightly (P=0.039 - 0.065). 
The association persisted after further adjustment for depressive symptoms (P=0.017). Fur-
ther adjustment for traditional risk factors and separate components of metabolic syn-
drome only waist girth decreased the association significantly. 
In the analysis by WHO definition of metabolic syndrome there was no association be-
tween hopelessness and metabolic syndrome after adjusting for traditional risk factors 
(with adjustment only for age: OR 1.4, CI 95% 1.1-2.0, P=0.020; with adjustment for age and 
traditional risk factors: OR 1.3, CI 95% 1.0-1.9, P=0.105).  
 
Hopelessness, depressive symptoms and metabolic syndrome.  There was a direct asso-
ciation between hopelessness and depressive symptoms as continuous variables (r=0.38)). 
The prevalence of depressive symptoms increased in a graded fashion with the hopeless-
ness categories (Table 1 of the Original Publications, Study I). However, adjustment for 
5 Results 
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depressive symptoms in the logistic regression analyses did not weaken the association of 
hopelessness with metabolic syndrome (upper vs. lower third, OR 2.1, 95% CI 1.4-3.4). 
Furthermore, there was no interaction between hopelessness and categories of depressive 
symptoms in the association with metabolic syndrome (e.g., for metabolic syndrome as 
defined by the NCEP, P=0.75 for the interaction). Use of different cut-offs for the dichoto-
mization of depressive symptoms or use of the HPL Depression Scale as a continuous 
variable also did not change the overall results (data not shown). 
5.2 DEPRESSIVE SYMPTOMS, LOW-GRADE INFLAMMATION AND DE-
VELOPMENT OF ABDOMINAL OBESITY AND METABOLIC SYNDROME 
(Study II) 
Baseline clinical characteristics. Men with both low-grade inflammation and depressive 
symptoms had a lower socio-economic status and consumed more alcohol and smoked 
more commonly than other participants (Table 1 of the Original Publications, Study II). 
They also had a higher BMI, larger waist girth and more unfavourable lipid profile. While 
men with both low-grade inflammation and depressive symptoms had a lower cardiores-
piratory fitness than others, their LTPA level was not significantly lower than the others’. 
The prevalence of cardiovascular disease increased in a graded fashion across the inflam-
mation and depressive symptom categories.  
 
The risk of abdominal obesity.  CRP alone predicted the development of waist girth >102 
cm (with adjustment for age: OR 2.43, Cl 95% 1.22-2.86, P<0.001; with adjustment for age, 
socioeconomic status, presence of cardiovascular disease, smoking, alcohol consumption, 
physical activity: OR 2.25, Cl 95% 1.44-3.51, P<0.001), but depressive symptoms did not 
(with adjustment for age: OR 1.54, Cl 95% 0.90-2.65, P=0.125; with adjustment for age and 
traditional risk factors OR 1.48, Cl 95% 0.83-2.63, P=0.207). 
Men with both low-grade inflammation and depressive symptoms were nearly 5 times 
more likely to develop a waist girth over 102 cm during the 11 years of follow-up than 
men with neither of these risk factors after adjusting for age (Figure 1; Table 2 of the 
Original Publications, Study II, P<0.001). After further adjustment for potential risk factors 
the risk was still over 4-fold (P=0.005). When further adjusting for BMI the trend was no 
longer significant (P=0.859).  
Similarly, when using a waist girth at least 94 cm, the risk of developing abdominal 
obesity was increased in men with both low-grade inflammation and depressive symp-
toms (with adjustment of age and traditional risk factors: OR 3.29, Cl 95% 0.95-11.43, 
P<0.001) 
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Figure 1. The risk (Odds Ratios) of developing abdominal obesity (waist girth >102 cm) in 11 
years according to low-grade inflammation and depressive symptoms 
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The risk of developing metabolic syndrome.  After adjustment for age and potential car-
diovascular risk factors (SES, presence of CVD, smoking, alcohol consumption, physical 
activity), men with  both low-grade inflammation and depressive symptoms were 4 times 
more likely develop metabolic syndrome during the 11 years (Figure 2; Table 2 of the 
Original Publications, Study II, P=0.001 and P=0.007, respectively). After further adjust-
ment for BMI, the association was no longer significant (P=0.393).   
 
 
 
 
Figure 2. The risk (Odds Ratios) of developing metabolic syndrome in 11 years according to 
low-grade inflammation and depressive symptoms 
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5.3 PHYSICAL ACTIVITY, CARDIORESPIRATORY FITNESS AND HOPE-
LESSNESS (Study III) 
Cross-sectional association of LTPA with hopelessness. After adjustment for age, men 
with at least moderate LTPA more than 2.5h/week had a 41% lower risk of being hopeless 
than men with ≤60 min moderate LTPA/week (Figure 3a; Table 2 of the Original Publica-
tions, Study III, P<0.001). After further adjustment for potential confounding or mediating 
factors (age, SES, presence of CVD, smoking, alcohol consumption, low-grade inflamma-
tion, BMI and depressive symptoms), the association remained significant (P=0.001-0.003).   
The association of vigorous LTPA with hopelessness was even stronger (Figure 3a; Ta-
ble 2 of the Original Publications, Study III). Total LTPA was similarly associated with 
hopelessness, but low-intensity exercise was not (Table 2 of the Original Publications, 
Study III). 
In additional analyses with separate adjustment of variables in Model 2 by VO2max, dia-
betes and metabolic syndrome, none of these potentially mediating factors weakened the 
association (data not shown). Adjusting for the separate components of metabolic syn-
drome (fasting serum HDL, triglycerides or insulin, fasting blood glucose, waist girth and 
blood pressure) did not alter the association of moderate-to vigorous or vigorous LTPA 
with hopelessness either. Furthermore, in the association with hopelessness there was no 
interaction between moderate-to-vigorous LTPA and diabetes (P=0.290), CVD (P=0.641), or 
metabolic syndrome (P=0.225 for the interaction). There also was no interaction between 
high-intensity LTPA and these variables for the association with hopelessness.  
   The men were categorized by VO2max tertiles to study whether cardiorespiratory fit-
ness modifies the association between moderate LTPA and hopelessness (Figure 1 of the 
Original Publications, Study III). The association seemed to be stronger in the most fit 
group, but the interaction term for VO2max and LTPA with respect to hopelessness was not 
significant (P=0.348). Physically unfit and physically inactive men were twice as likely to 
feel hopeless than fit and physically active men. 
 
LTPA, hopelessness and depressive symptoms. HPL depression score and hopelessness 
score correlated moderately (r=0.38, P<0.001). The average HPL depression score in men in 
the highest third of hopelessness categories was higher than in the lower tertiles (Table 1 
of the Original Publications, Study III). However, in the logistic regression analysis ele-
vated depressive symptoms did not decrease the associations of moderate or vigorous 
LTPA and hopelessness (Figure 3b; Table 2 of the Original Publications, Study III, P=0.003 
and P<0.001 respectively). Moreover, there was no interaction between LTPA and depres-
sive symptoms in the association with hopelessness (moderate LTPA P=0.380, vigorous 
LTPA P=0.957 for the interaction). In separate analyses, depressive symptoms and LTPA 
were not associated. 
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Figure 3a. Decrease in risk (in percentages) of hopelessness according to physical activity cat-
egories at baseline 
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Figure 3b. Decrease in risk (in percentages) of hopelessness according to physical activity cat-
egories at baseline 
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Association of cardiorespiratory fitness with hopelessness. Men with VO2max over 35.7 ml 
 kg-1  min-1 were 47% less likely to express feelings of hopeless than those with VO2max 
below 28.9. ml  kg-1  min-1 after adjusting for age (Figure 4). After further adjustment for 
potentially confounding variables, cardiorespiratory fitness was still associated with hope-
lessness (Table 2 of the Original Publications, Study III P=0.003-0.037). After further ad-
justment separately for potential mediating factors, such as LTPA, diabetes, CVD and 
metabolic syndrome, the association remained significant (data not shown). Of the com-
ponents of metabolic syndrome, only waist girth attenuated the association between 
VO2max and hopelessness significantly (data not shown). Moreover, there were no interac-
tion between VO2max and diabetes (P=0.113), cardiovascular disease (P=0.196) or metabolic 
syndrome (P=0.785 for the interaction) in the association with hopelessness. 
 
Cardiorespiratory fitness, hopelessness and depressive symptoms. Unlike with physical 
activity, after adjusting for depressive symptoms the association of cardiorespiratory fit-
ness with hopelessness was no longer significant (Figure 4; Table 2 of the Original Publica-
tions, Study III). There was no interaction between VO2max and depression in the associa-
tion of VO2max with hopelessness (P=0.109).  
 
 
 
Figure 4. Decrease in risk (in percentages) of hopelessness according to cardiorespiratory fit-
ness 
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5.4 PHYSICAL ACTIVITY AND RISK OF HOPELESSNESS (Study IV) 
Baseline characteristics. Men who developed hopelessness at the follow-up had lower 
socioeconomic status and were more often smokers at baseline than the less hopeless men 
at baseline (Table 1 of the Original Publications, Study IV).  
 
LTPA and hopelessness. Similarly to the baseline analysis, cross-sectional analyses at 4 
years and 11 years of follow-up showed that LTPA and hopelessness were connected after 
adjustment for traditional risk factors (e.g. 4-year follow-up, total LTPA: OR 0.65, 95% Cl 
0.45-0.94, P=0.015; vigorous LTPA: OR 0.70, 95% Cl 0.48-1.02, P=0.037; moderate-to-
vigorous LTPA: OR 0.67, 95% Cl 0.47-0.95, P=0.008; 11-year follow-up, total LTPA: OR 
0.76, 95% Cl 0.50-1.17, P=0.188; vigorous LTPA: OR 0.66, 95% Cl 0.43-1.01, P=0.042; moder-
ate-to-vigorous LTPA: OR 0.52, 95% Cl 0.33-0.80, P=0.003). Low-intensity LTPA was not 
associated with hopelessness at any of the time points. 
 
LTPA and the risk of developing hopelessness during 4-year follow-up. Men who re-
ported at least 2.5 hours of moderate-to-vigorous LTPA per week were 42% more likely 
(Figure 5; OR 0.58, 95% Cl 0.35-0.96, P for trend=0.023) to feel hopeless 4 years later than 
physically inactive men adjusting for age (Table 2 of the Original Publications, Study IV). 
The association weakened slightly after further adjustment for smoking, alcohol consump-
tion, cardiovascular disease and adulthood socioeconomic status as well as after addi-
tional adjustment for depressive symptoms (Figure 5). Further adjustment for V02max and 
BMI had no effect on the association.   
Total LTPA, vigorous LTPA, and low-intensity LTPA did not predict hopelessness at 
the 4-year follow-up (Table 2 of the Original Publications, Study IV). Furthermore, V02max 
was not associated with the development of hopelessness during the 4-year follow-up. 
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Figure 5. Decrease in risk (in percentages) of hopelessness during 4 years according to mod-
erate-to-vigorous physical activity. 
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LTPA and the risk of developing hopelessness during the 11-year follow-up. An age-
adjusted logistic regression model showed that moderate-to-vigorous LTPA at baseline 
reduced the risk to develop feelings of hopelessness during 11 years of follow-up (Figure 
6; Table 2 of the Original Publications, Study IV with adjustment for age, OR 0.53, 95% Cl 
0.29-0.99, P=0.049). After controlling for confounding variables the trend remained similar 
(OR 0.59, 95% Cl 0.32-1.12), but the association was no longer significant (P=0.108).  Vigor-
ous LTPA was similarly associated with hopelessness, but total LTPA and low-intensity 
LTPA did not predict hopelessness at the 11-year follow-up. V02max also was not associated 
with the development of feelings of hopelessness at the 11-year follow-up (data not 
shown). 
Furthermore, in the association with emergence of hopelessness there was no interac-
tion between moderate-to-vigorous LTPA and diabetes (P=0.21), CVD (P=0.12) or meta-
bolic syndrome (P= 0.29 for the interaction). There also was no interaction between high-
intensity LTPA and these variables for the association with development of hopelessness.  
 
 
 
 
 
Figure 6. Decrease in risk (in percentages) of hopelessness during 11 years according to mod-
erate-to-vigorous physical activity. 
 
 
Hopelessness and the risk of becoming physically inactive during follow-up. Men who 
were hopeless at baseline were not at risk for becoming physically inactive during the 4-
year follow-up (for ≥2.5 h/wk vs. <1 h/wk, moderate-to-vigorous LTPA, with adjustment 
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for age: OR 0.70, CI 95% 0.42-1.15, P for trend 0.15; with adjustment for age and traditional 
risk factors (presence of CVD, SES, smoking and alcohol consumption): OR 0.89, CI 95% 
0.52-1.51, P=0.58) or during the 11-year follow-up (with adjustment for age: OR 0.57, CI 
95% 0.29-1.11, P for the trend 0.14; with adjustment for age and traditional risk factors: OR 
0.79, CI 95% 0.39-1.61, P=0.64). Those men already exercising less than hour per week 
moderate-to-vigorous physical activity at baseline (n=951, 36%) were excluded from this 
analysis. Moreover, there was no association between changes in LTPA and changes in 
hopelessness scores during the follow-up period (data not shown). 
 
LTPA, hopelessness and depressive symptoms. Depression and hopelessness at baseline 
correlated moderately (r=0.38, P<0.001). The average depression score value at baseline 
was higher in hopeless men than in other men, although the difference was not significant 
(Table 1 of the Original Publications, Study IV). LTPA did not predict development of de-
pressive symptoms (data not shown). 
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6.1 METHODOLOGICAL ASPECTS  
6.1.1 Study population and design 
The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD), with its large database 
and long follow-up period, offered a unique opportunity to study cross-sectional and lon-
gitudinal relations of psychosocial factors, physical activity, obesity and metabolic syn-
drome. The large study population represents a sample of middle-aged men from Eastern 
Finland, and the findings can be generalized to other male population of European back-
ground. Women were not included in the study. Therefore, further research is required to 
know how the findings apply for women or other ethnic groups.  
The participation rate in the baseline examinations was high. However, cross-sectional 
design (Study I and III) does not allow conclusions of causality to be drawn. In the pro-
spective studies (Study II and IV), the follow-up period was relatively long and the de-
sign enabled the consideration of temporality of the associations. Some statistical power 
was lost during the long follow-up.  Adjustment for potential confounding and mediating 
variables was done, but residual confounding may remain. 
6.1.2 Definitions of metabolic syndrome 
In this thesis, the definitions of metabolic syndrome of the NCEP, the IDF and the WHO 
were used. Despite strong efforts by the global medical community, a unified definition of 
metabolic syndrome does not exist. This has lead to confusion and disagreement over its 
relevance as a clinical tool.  However, there is consensus that abdominal obesity, high 
blood pressure, unfavorable lipid profile, and dysglycemia coexist and share a common 
underlying mechanism which increases the risk of CVD and especially diabetes (Alberti et 
al. 2009). The question whether metabolic syndrome predicts the increase in risk more 
than the sum of its components still remains debated.  As Simmons et al. (2010) stated, the 
concept of metabolic syndrome also faces other limitations: The cut-offs of the continuous 
variables are artificial and therefore very controversial. The definition excludes many im-
portant risk factors for CVD and diabetes, such as sex, age, LDL cholesterol and behavioral 
variables. The WHO Expert consultation emphasizes that metabolic syndrome should not 
be used as a clinical diagnosis, but seen as a pre-morbid condition that increases the life-
time risk for CVD and diabetes (Simmons et al. 2010). Defining metabolic syndrome al-
lows assessment of chronic disease risk within populations and comparisons between dif-
ferent countries and enhances understanding of the common pathogenesis of CVD risk 
factors. It also helps to predict relative risk of patients in clinical work and provides a clear 
public health message that underlines the importance of risk factor clustering in chronic 
disease prevention and management (Simmons et al. 2010). 
6.1.3 Assessment of depressive symptoms and hopelessness 
Depressive symptoms were measured using self-reported questionnaire instead of stan-
dardized interviews. Although the questionnaire is designed for epidemiological use 
rather than clinical diagnosis, it has been well validated (Roberts and O’Keefe 1981; Kap-
6 Discussion 
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lan et al. 1987) and widely used in the prediction of various cardiovascular and metabolic 
outcomes and as an outcome itself (Roberts and O’Keefe 1981; Kaplan et al. 1987; Everson 
et al. 1998; Tolmunen et al. 2003, 2004a, 2004b, 2006). The Finnish version of the HPL De-
pression Scale has been used previously, as well (Tolmunen et al. 2003, 2004a, 2004b, 
2006). The HPL depression scale is significantly correlated with the Beck Depression In-
ventory in an outpatient population (r=0.66), and it is also similar to other questionnaires, 
such as the Center for Epidemiologic Studies Depression scale (Kaplan et al 1987). A cut-
off ≥5 has been used previously to classify men with depressive symptoms (Kaplan et al. 
1987; Everson et al. 1998). Therefore the same cut-off point was used in this study. In a 
previous study, men who had five or more depressive symptoms from the HPL Depres-
sion Scale, 65% met the criteria for a current major depressive episode according to DSM-
III-R criteria (Everson et al. 1998). 
Unfortunately, depressive symptoms were only assessed at baseline and at 4-year fol-
low-up. Therefore the bidirectional relationship between the variables of interest could not 
have been investigated at 11 year follow-up. Hopelessness was also measured using self-
reported questionnaires instead of standard interviews. The hopelessness score was based 
on only two items. Therefore, this hopelessness scale is fairly simple, and it has not been 
compared with other hopelessness scales. Nevertheless, this scale has consistently pre-
dicted adverse outcomes, including development of hypertension, progression of carotid 
atherosclerosis, incident ischemic heart disease and overall mortality, independently of 
depressive symptoms (Everson et al. 1996, 1997, 2000, Whipple et al. 2009). Moreover, 
hopelessness assessed with only a single-item scale has predicted incident ischemic heart 
disease in 2800 men and women participating in the National Health Examination Follow-
up Survey more strongly than depression (Anda et al. 1997). This suggests that feelings of 
hopelessness and futility can be assessed by a rather simple tool in a health care setting.  
The HPL Depression scale does not include an item on hopelessness and correlation 
between these scales is only moderate (r=0.38). The correlation of this hopelessness scale 
with other depressive symptom questionnaires (Everson et al. 1996, 2000) is very similar, 
indicating that the scale measures feelings of futility that do not directly reflect depressive 
symptoms in general. 
The hopelessness score was divided into tertiles, and the cut-off for the highest tertile 
was 4 points. In the prospective study, this cut-off was used to define men with high level 
of hopelessness. In previous studies, 5 and 6 points have also been used as cut-offs to indi-
cate high level of hopelessness (Everson et al. 1996, 1997, 2000). 
6.1.4 Assessment of low-grade inflammation 
Cut-offs for CRP of 1 and 3 mg/l have been suggested to define low, moderate and high 
risk groups for cardiovascular disease. In this study an intermediate cut-off of 2 mg/l was 
used to define low and high-risk groups. Using 3 categories or cut-off of 3 mg/l resulted in 
too few individuals to allow for assessment of the combined effects of low-grade inflam-
mation and depressive symptoms on the development of abdominal obesity.  
CRP was the only marker used to assess low-grade inflammation. It is a well-known 
cardiovascular risk marker, however, with a long half-life and little diurnal variation (La-
aksonen et al. 2005b; Pearson et al. 2003). The concentration of CRP in blood rises consi-
derably in conditions like bacterial infection and large tissue injury. This needs to be taken 
into account when outcomes of low-grade inflammation are investigated. 
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6.1.5 Assessment of waist girth 
Abdominal obesity was defined as waist girth >102cm. This cut-off was used for abdomi-
nal obesity as an endpoint at the 11-year follow-up. Using waist girth of ≥94cm lead to 
similar findings, but there was smaller number of participants in the outcome group. The 
NCEP definition of metabolic syndrome uses waist girth >102cm (NCEP 2001), whereas 
the IDF uses a cut-off of ≥94cm in their criteria (Zimmet et al. 2005). These two cut-offs 
have corresponded to BMI values of over-weight (>25kg/m2) and obesity (>30kg/m2) (Lean 
2000). However, in this cohort BMI value of >25kg/m2 corresponded to waist girth of 87cm 
(Laaksonen 2002a), indicating that this waist girth cut-offs correlate to considerably higher 
BMI values in non-diabetic Finnish male population. 
6.1.6 Assessment of physical activity and cardiorespiratory fitness 
Precise assessment of LTPA by self-reports is complicated. Previous studies using objec-
tively assessed estimates of physical activity show remarkably lower levels of physical 
activity compared with self-reports (Hagströmer et al. 2007). The KIHD Risk Factor study 
begun in the early 1980’s when objective measurements of physical activity were not feasi-
ble. The validated KIHD 12-month Leisure-time Physical Activity Questionnaire provides, 
however, detailed information on frequency, duration and intensity of physical activity 
recalled for the preceding 12 months. The test-retest reliability of the questionnaire was 
accurate when readministered 12 months later (Lakka et al. 1992). Duration of vigorous 
LTPA also correlated well with age-adjusted cardiorespiratory fitness (Lakka et al. 1992). 
Nevertheless, the long time-frame makes the questionnaire vulnerable to recall bias. The 
subjective intensity classification may also allow participants to overestimate the true in-
tensity of exercise (Lakka et al. 1994).  
A major strength of the studies is that VO2max was measured directly by a maximal 
symptom-limited cycle ergometer exercise test with analysis of respiratory gas exchange, 
which is an accurate and highly reproducible measure of cardioresipiratory fitness 
(Åstrand and Rodahl 1986).  
6.2 HOPELESSNESS AND METABOLIC SYNDROME 
This study showed for the first time that hopelessness is strongly associated with meta-
bolic syndrome (Study I). Men with a hopelessness score in the highest third were 2.2 
times more likely to have metabolic syndrome than men in the lowest third, and nearly 
two times more likely even after adjusting for BMI and traditional risk factors. After con-
trolling depressive syndromes in general the risk was still 2.1 times higher. Similar find-
ings were seen with the use of IDF definition of metabolic syndrome instead of the NCEP 
definition. The association with metabolic syndrome as defined by the WHO did not reach 
significance, however. The WHO criteria emphasize insulin resistance, or in this study, its 
proxy hyperinsulinemia, rather than abdominal obesity, as in the NCEP and IDF criteria 
(Laaksonen et al. 2004a). Furthermore, the less commonly used WHO definition is not 
generally applicable clinically because of its emphasis on a more or less direct measure of 
insulin resistance. It is not clear why hopelessness was not associated with metabolic syn-
drome as defined by the WHO, but it is conceivable that hopelessness plays a more impor-
tant role in some phenotypes of metabolic syndrome than others. The importance of hope-
lessness on physical and mental health has been recognized. In previous studies hopeless-
ness has been found to predict various cardiovascular outcomes, independently of depres-
sion (Everson et al. 1996, 1997, 2000, Do et al. 2010, Whipple et al. 2009).  
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In this study the association of hopelessness and metabolic syndrome seemed to be ex-
plained mostly by waist girth. Nevertheless, after adjusting for traditional risk factors and 
waist girth the association of hopelessness and metabolic syndrome defined by NCEP re-
mained significant. 
6.3 DEPRESSIVE SYMPTOMS, LOW-GRADE INFLAMMATION AND AB-
DOMINAL OBESITY 
The association between depression and obesity has been well studied. The overall body 
of evidence suggests that the association is bidirectional, although discrepancies exist, 
probably due to methodological differences (Luppino et al. 2010; Atlantis et al. 2009). A 
previous prospective study in this cohort reported that low-grade inflammation increases 
the risk of metabolic syndrome and diabetes (Laaksonen et al. 2004b). The present study 
showed a similar prognostic effect of CRP level on development of unfavorable circumfe-
rence (Study II). Thus, elevated serum CRP level alone predicted central obesity, but in 
the presence of depressive symptoms the risk was increased considerably. Men with both 
low-grade inflammation and depressive symptoms were 4.3 times more likely to develop 
waist girth over 102 cm during 11 years than men with neither of these risk markers even 
after adjusting for traditional risk factors. However, after adjustment for BMI the associa-
tion was no longer significant. Similar findings were seen when using metabolic syndrome 
as outcome.  
It is expected that a hopeless or depressed person is more likely to follow an unhealthy 
life-style and be less likely to make favorable behavioral changes (Blumenthal et al. 1982). 
In this study, however, traditional life-style risk factors such as smoking, alcohol con-
sumption and physical inactivity did not change the relationship between depressive 
symptoms and metabolic outcomes.  
The evidence of possible mechanisms explaining these associations comes from neu-
roendocrine studies of depression. It is plausible, however, that these mechanisms also 
apply to separate depressive symptoms such as hopelessness. Activation of the HPA sys-
tem and elevated glucocorticoid concentrations may be underlying factors in the associa-
tion of depressive symptoms and obesity (Luppino et al. 2010).  
Low-grade inflammation may also mediate the correlation between depressive symp-
toms and obesity. In this study a graded increase in the concentrations of C-reactive pro-
tein was found across the hopelessness categories, even though adjustment for CRP and 
fibrinogen did not alter the association between hopelessness and metabolic syndrome. In 
addition, men with both low-grade inflammation and depressive symptoms were more 
likely to develop abdominal obesity over long period of time than men with neither of 
these risk markers. Thus, although low-grade inflammation certainly has consequences on 
metabolism of adipose tissue, independent of mood disturbances, together with depres-
sive symptoms the effect may be even more damaging.  
As expected, BMI weakens the association of CRP and depressive symptoms with de-
velopment of waist girth due to the interrelationship of central obesity and overall obesity. 
On the other hand, attenuation of the association when adjusting by BMI suggests that 
obesity partly mediates the association.  
Several behavioral factors and biological factors are connected in this complex, multi-
directional relation of depression, low-grade inflammation and abdominal obesity. Physi-
cal inactivity and high alcohol consumption are well known to increase the accumulation 
of visceral fat (Laaksonen 2002b). Both factors are also associated with low-grade inflam-
mation and depression (O’Connor and Irwin 2010; Mead et al. 2009). However, in this 
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study, lifestyle risk factors did not entirely explain the role of inflammation and depres-
sive symptoms in the development of central obesity. Use of psychotropic medication is 
also suggested to result in weight gain (Luppino et al. 2010). In this study, those using an-
tidepressants at baseline were excluded from the study. Furthermore, physical and psy-
chological health may interact together in a biological level that is yet to be discovered. 
6.4 PHYSICAL ACTIVITY AND HOPELESSNESS  
All adults are recommended to engage in at least 30 min of moderate-intensity exercise 5-7 
days per week to prevent chronic diseases (Physical Activity Guidelines Advisory Com-
mittee Report, 2008). Cross-sectional analyses of the baseline study (Study III) and at 4 
years and 11 years of follow-up (Study IV) showed that men following the recommended 
physical activity guidelines had fewer feelings of hopelessness than physically inactive 
men after adjustment for traditional risk factors and potential mediating factors. Impor-
tantly, men engaging in moderate-to-vigorous LTPA at least 2.5 hours per week at base-
line had 35% lower risk to feel hopeless about their future and reaching goals 4 years later 
than physically inactive men at baseline, after adjustment for confounding factors (Study 
IV). After 11 years the trend was still similar, indicating protective effect of LTPA. How-
ever, the association was no longer significant, possibly due to loss of statistical power. It 
is important to note that hopelessness at baseline did not predict physically inactive life-
style 4 or 11 years later. The results of the present study suggest that physically inactive 
lifestyle predisposes to hopelessness, rather than vice versa.  
The effect of depressive symptoms on the cross-sectional associations of LTPA and VO2max 
with hopelessness was distinctly different. Odds ratios for total, moderate and vigorous 
LTPA for hopelessness were not attenuated in logistic models adjusting further for de-
pressive symptoms, whereas the association of VO2max and hopelessness was no longer 
significant. Cardiorespiratory fitness was strongly associated with elevated depressive 
symptoms even after adjustment for various potential confounding and mediating factors. 
The relationship between LTPA and depression, however, was not found in this cohort, as 
reported previously (Tolmunen et al. 2006). This suggests that hopelessness and depres-
sion are overlapping, but distinct entities. The findings also suggest that moderate or vi-
gorous LTPA may ameliorate or protect against feelings of hopelessness even if VO2max 
does not improve. Considering that physical activity did not protect against depressive 
symptoms in general, it is plausible that physical activity has stronger impact on certain 
depressive symptoms than the others.   
Furthermore, in the prospective analysis, cardiovascular fitness did not protect against 
hopelessness. The distinction between hopelessness and depression could explain the dif-
ference in the associations of hopelessness with LTPA and VO2max. It is important to note, 
however, that cardiorespiratory fitness is only partly a reflection of physical activity. Al-
though moderate and vigorous LTPA obviously has an effect on VO2max, it is also deter-
mined partly by genetic factors (Bouchard and Rankinen 2001). How this may relate to 
feelings of hopelessness and depression is still unclear. 
Interestingly, Thirlaway and Benton (1992) reported that subjects who were physically 
inactive and fit had poorer mood that those who were inactive and unfit in a cross-
sectional setting. They argued that fitness could be reflection of a former active lifestyle, 
and therefore to quit exercising may be stressful and depressing. Lampinen et al. (2000) 
showed that older adults who reduced their intensity of physical exercise during 8 years 
had more depressive symptoms at follow-up than those who remained active or increased 
their physical activity. Also a study by Motl et al. (2004) indicated that changes in physical 
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activity were associated with risk of depression in 2 years among adolescents. Hypotheti-
cally, a fit person, however, may be especially in need of physical activity to maintain pos-
itive mood, and a temporary lack of exercise could be especially damaging for their mental 
health.   
This study agrees with growing evidence that regular LTPA contributes to mental 
health. Prospective studies are still scarce, however. While a few large cohort studies sug-
gest that physical activity protects against depressive symptoms (Camacho et al. 1991; Paf-
fenbarger et al. 1994; Strawbridge et al. 2002; Motl et al. 2004; Wise et al. 2006; Ströhle et al. 
2007), others do not (Cooper-Patrick et al. 1997; Kritz-Silverstein et al. 2001, Wiles et al. 
2007). In previous studies psychological outcome has been measured in various ways, va-
rying from clinical depression to depressive symptoms and mood. Conflicting results 
could be partly caused by diversity in measurements of effects of physical activity on dif-
ferent depressive symptoms 
Previous studies have shown that long-term exposure to systemic low grade inflamma-
tion may lead to progression of chronic diseases (Beavers et al. 2010). Inflammation is hy-
pothesized to play a role in the development of depression (Howren et al. 2009), as well as 
metabolic diseases (Laaksonen et al. 2004b, 2005b). Physical activity is also related to lower 
systemic inflammation (Nicklas et al. 2005, Beavers et al. 2010). Future research will reveal 
whether systemic low-grade inflammation is the common denominator explaining the re-
lationship between depressive symptoms, physical activity and metabolic syndrome. 
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1. Non-diabetic, middle-aged men with high levels of hopelessness were more likely 
to have metabolic syndrome than men who are less hopeless, independently of tra-
ditional risk factors, BMI and other depressive symptoms. This finding brings a 
new perspective to the only partly understood pathogenesis of metabolic syndrome 
and adds to the growing evidence of negative impacts of hopelessness on physical 
health. 
2. Non-diabetic men with both low-grade inflammation and depressive symptoms 
were more likely to develop abdominal obesity (waist girth at least 102 cm) during 
11 years than men with neither of these risk markers even after adjusting for tradi-
tional risk factors.  These men were also more likely to develop metabolic syn-
drome. The findings suggest that the presence of both low-grade inflammation and 
depressive symptoms identify men at an especially high risk to develop abdominal 
obesity and metabolic syndrome. 
3. Physically active middle-aged men were less likely to feel hopeless about their fu-
ture and reaching goals than physically inactive men. Cardiorespiratory fitness was 
also related to reduced feelings of hopelessness, but this association was partially 
explained by depressive symptoms. Considering that hopelessness is an important 
determinant of mortality, cardiovascular morbidity and low subjective well-being, 
this study provides additional evidence for the health benefits of physical activity 
and fitness. 
4. After adjusting for potential confounding factors, men engaging in moderate-to-
vigorous LTPA had lower risk to feel hopeless about their future and reaching goals 
4 years later than physically inactive men at baseline. After 11 years the trend was 
still similar, indicating protective effect of LTPA. However, the association was no 
longer significant. This study agrees with growing evidence that regular LTPA con-
tributes to mental health. The new finding of this study is that a physically active 
lifestyle helps people to maintain or gain more optimistic perspective on the future 
and oneself. 
 
These studies suggest that following the recommended physical activity guidelines may 
help to confront challenges in life and to enhance optimism and subjective well-being. 
Therefore moderate to vigorous physical activity should be promoted to improve mental 
health. These studies also suggest that in addition to focusing on the traditional risk fac-
tors of cardiovascular disease, the emotional state and expectations of individuals should 
be taken into account in the prevention and treatment of metabolic syndrome and its con-
sequences. Physical and psychological health and performance are interdependent, possi-
bly to an even greater extent than science currently understands.  
 
7 Summary and Conclusions 
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This study brings a new perspective to the only partly understood pathogenesis of abdo-
minal obesity and metabolic syndrome. In addition to focusing on the traditional risk fac-
tors of cardiovascular disease, the emotional state and expectations of individuals should 
be taken into account in the prevention and treatment of metabolic syndrome and its con-
sequences. Feelings of hopelessness and futility can be rather easily assessed in a primary 
care setting. Assessment of hopelessness may allow targeting of individuals in whom 
more intensive lifestyle and pharmacological treatment of metabolic, cardiovascular and 
psychosocial risk factors could improve long-term cardiovascular outcome and quality of 
life. In addition, the presence of both low-grade inflammation and depressive symptoms 
seem to identify men at an especially high risk to develop abdominal obesity and metabol-
ic syndrome. Screening depressive men with high low-grade inflammatory markers could 
also help to target high risk subjects for prevention and treatment of metabolic syndrome 
and its consequences. 
This study adds to the growing evidence that regular LTPA also contributes to mental 
health. A physically active lifestyle not only helps one live a healthier life, but it may also 
improve well-being by helping to maintain a positive attitude and optimistic perspective 
on the future and oneself. In the future, more research should be carried out by utilizing 
recent technological advances, motor sensors and physiological monitoring, to allow 
greater accuracy and precision of the assessment of physical activity. Furthermore, more 
evidence-based data from randomized controlled trials are needed on the effects of physi-
cal activity on mental health.  
Traffic safety, vaccinations and preventing secondary smoking are public health issues 
that have become social norms, the importance of which most people do not question in 
everyday decisions. By contrast, governmental programs to enhance physical activity are 
still inadequate. The prevalence of physical inactivity is higher than any other modifiable 
risk factor for cardiovascular and metabolic diseases (Warburton et al. 2006). Based on self-
reported measures, 45-62% of the western populations reach the recommended physical 
activity level at least 30 min of moderate-intensity exercise per day. Objectively assessed 
estimates of physical activity show remarkably lower values (Hagströmer et al. 2007). 
Therefore, physical inactivity is a major public health risk factor that still has a great po-
tential to be modified and gain enormous health benefits. Policy makers, corporations, 
employers and public health workers must work in tandem to support and promote an 
active environment, as both an essential method of disease prevention and as an invest-
ment in future productivity and wellbeing. Most essential, however, is that everyone ac-
knowledges the individual responsibility in personal well-being and accepts a physically 
active lifestyle as the social norm.  
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ture, has been shown to be a pre-
dictor of cardiovascular morbidity 
and mortality, independently of 
depression. This study indicates 
that hopelessness is also associ-
ated with metabolic syndrome. 
Additionally, physical activity is 
inversely associated with feelings 
of hopelessness. Regular physical 
activity may protect one from an 
emergence of hopelessness, and 
thus enhance subjective well-be-
ing and an optimistic perspective 
in life.   
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